Sidley advised Biodesix, Inc. (NASDAQ: BDSX), a Boulder-based biotech company, in connection with its initial public offering of US$72 million. Biodesix sold four million shares of its common stock at US$18 per share.
The Sidley team was led by Global Life Sciences partner Frank Rahmani (Palo Alto and San Francisco) and Capital Markets partner Sam Gandhi (New York), and associates Nicole Garrett, Riley Kelleher, Betsy Mead (each New York), and Nick DeAngelis (Palo Alto). Other critical support was provided by Life Sciences Transactions partner Tom Duley (San Francisco); Regulatory partners Donielle McCutcheon (Chicago), Colleen Brown (Washington, D.C.), Diane McEnroe (New York), and associates Brigid DeCoursey Bondoc, Rachael Hunt, and Jon Zucker (each Washington, D.C.); Executive Compensation and Benefits partner Audry Casusol (New York) and associates Teresa Napoli and Li Wang (each Chicago); Securities Enforcement and Regulatory (Section 16) partner Katie Klaben (Washington, D.C.), associate Erica Robertson (Washington, D.C.), and staff attorney Alyssa Locnikar (Washington, D.C.); Tax partner Rachel Kleinberg (Palo Alto) and associate Jonathan Westreich (Los Angeles).
